PLX Pharma Sets IPO Offering Range

Houston-based PLX Pharma set its estimated IPO offering range on Friday, saying in a filing that it expects to sell 3,800,000 shares of its common stock at between $17.00 and $19.00 per share. The company's IPO is being underwritten by Raymond James, Maxim Group LLC, and Janney Montgomery Scott. PLX Pharma is developing specialty pharmaceuticals, aimed at safer and more effective delivery of aspirin products. The company is venture backed by Aurus Bios Fondo de Inversion Privado and Integra Ventures. The company has filed to trade on the NASDAQ Capital Market as PLXP.